OXURION (EBR:OXUR) | Finanzwire

Basculer en Français

9480	Companies
185527	Keywords
117915	Articles
99372	Press releases

Home
Companies
OXURION

BRIEF

published on 06/19/2025 at 08:35, 5 months 16 days ago

Oxurion to Acquire Preclinical Microbiology CRO in Toulouse

Acquisition Diversification Toulouse Oxurion Microbiology CRO
PRESS RELEASE

published on 06/19/2025 at 08:30, 5 months 16 days ago

Oxurion signs a letter of intent for the planned acquisition of a preclinical microbiology CRO to diversify and strengthen its presence in the Toulouse region
Oxurion NV announces LOI to acquire 70% share capital of preclinical microbiology services company. Economic details of the transaction and growth projections disclosed

Acquisition Transaction Details Growth Projections Oxurion NV Preclinical Microbiology
BRIEF

published on 06/18/2025 at 18:05, 5 months 17 days ago

Oxurion Announces Transparency Notification from Atlas Special Opportunities II LLC

Transparency Notification Biopharmaceutical Atlas Special Opportunities Ownership Structure Oxurion
PRESS RELEASE

published on 06/18/2025 at 18:00, 5 months 17 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV announces receipt of transparency notification from Atlas Special Opportunities II, LLC regarding shareholding. Company combines therapeutic innovation with technology for clinical research

Clinical Research Transparency Notification Biopharmaceutical Belgium Oxurion NV
BRIEF

published on 06/12/2025 at 18:05, 5 months 23 days ago

Oxurion Reports Transparency Notification Amendments

Transparency Notification Biopharmaceutical Industry Shareholding Changes Oxurion NV Atlas Special Opportunities II
PRESS RELEASE

published on 06/12/2025 at 18:00, 5 months 23 days ago

Oxurion Receives Amended Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV received transparency notifications from Atlas Special Opportunities II, LLC regarding its share ownership crossing thresholds under Belgian Transparency legislation. Oxurion is a biopharmaceutical company focusing on therapeutic innovation and clinical research technologies

Clinical Research Transparency Notification Biopharmaceutical Oxurion NV Belgian Legislation
BRIEF

published on 06/12/2025 at 08:35, 5 months 23 days ago

Oxurion progresses in its acquisition of Axiodis

Acquisition Life Sciences Oxurion Axiodis FDI France
PRESS RELEASE

published on 06/12/2025 at 08:30, 5 months 23 days ago

Oxurion moves forward with the planned acquisition of Axiodis
Oxurion NV announces the lifting of a key condition precedent related to the acquisition and focuses on finalizing the transaction and strategic discussions for creating synergies with Axiodis CRO

Acquisition Biopharmaceutical Clinical Data Oxurion NV Strategic Discussions
BRIEF

published on 06/11/2025 at 18:05, 5 months 24 days ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC

Actions Transparency Biopharmaceuticals Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 06/11/2025 at 18:00, 5 months 24 days ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
Oxurion NV receives transparency notifications regarding share holdings from Atlas Special Opportunities II, LLC, impacting threshold percentages

Share Holdings Oxurion NV Belgian Transparency Legislation Transparency Notifications Atlas Special Opportunities II, LLC

Accesswire

Published on 12/05/2025 at 18:45, 24 minutes ago

Four Global Markets, One Engine: SMX Just Redefined What a Supply Chain Can Prove
Published on 12/05/2025 at 18:20, 49 minutes ago

NuRAN Announces Intention to Complete Consolidation in Preparation to the Restructuring Transaction
Published on 12/05/2025 at 18:00, 1 hour 9 minutes ago

SMX: A New Supply Chain Reality in the World's Four Largest Markets
Published on 12/05/2025 at 17:15, 1 hour 54 minutes ago

TRX GOLD Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 17:00, 2 hours 9 minutes ago

Three Trillion-Dollar Frontiers, One Technology: How SMX Is Everywhere at Once

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 18:58, 11 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 42 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 53 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:51, 1 hour 17 minutes ago

Issue of Equity
Published on 12/05/2025 at 17:46, 1 hour 23 minutes ago

Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds

Les Echos

Published on 12/05/2025 at 17:18, 1 hour 51 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 3 hours 58 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 08:45, 10 hours 24 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 1 day 1 hour ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 1 day 1 hour ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

View all LES ECHOS COMFI WIRE